BlackRock Inc. - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$47,000
-38.2%
20,9810.0%0.00%
Q2 2021$76,000
-41.5%
20,981
-20.0%
0.00%
Q1 2021$130,000
+0.8%
26,2350.0%0.00%
Q4 2020$129,000
+25.2%
26,2350.0%0.00%
Q3 2020$103,000
-18.3%
26,2350.0%0.00%
Q2 2020$126,000
-7.4%
26,2350.0%0.00%
Q1 2020$136,000
-48.1%
26,2350.0%0.00%
Q4 2019$262,00026,235
+62364.3%
0.00%
Q3 2019$0420.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,815,500$8,950,0000.30%
Sterling Financial Planning, Inc. 1,171$6,0000.01%
UBS Group AG 3,991$20,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$13,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,656$62,0000.00%
North Star Investment Management Corp. 20$00.00%
MORGAN STANLEY 466$2,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders